Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients
- Conditions
- Interventions
TVB- 2640 in Combination With Bevacizumab in Patients With First Relapse of High Grade Astrocytoma
- First Posted Date
- 2017-01-26
- Last Posted Date
- 2023-06-15
- Target Recruit Count
- 25
- Registration Number
- NCT03032484
- Locations
- 🇺🇸
University of Texas Health Science Center San Antonio at the Cancer Therapy and Research Center, San Antonio, Texas, United States
Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis
- Conditions
- Locations
- 🇺🇸
Cancer Therapy & Research Center at UTHSCSA, San Antonio, Texas, United States
MLN8237 for a Subject With Adenocarcinoma of the Prostate
- Conditions
Breast, Omega 3 Free Fatty Acid, Ph 0
- First Posted Date
- 2016-12-19
- Last Posted Date
- 2021-03-17
- Target Recruit Count
- 21
- Registration Number
- NCT02996240
- Locations
- 🇺🇸
CTRC at University of Texas Health Science Center San Antonio, San Antonio, Texas, United States
Paradoxical Stimulation of Hepatic Glucose Production With Dapagliflozin
- First Posted Date
- 2016-12-07
- Last Posted Date
- 2019-12-18
- Target Recruit Count
- 30
- Registration Number
- NCT02984644
- Locations
- 🇺🇸
University of Texas Health Science Center, San Antonio, Texas, United States
Effect of Dapagliflozin on Hepatic and Renal Glucose Metabolism Subjects
- First Posted Date
- 2016-12-05
- Last Posted Date
- 2024-03-04
- Target Recruit Count
- 32
- Registration Number
- NCT02981966
- Locations
- 🇺🇸
University of Texas Health Science Center, San Antonio, Texas, United States
Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM
- Conditions
- Interventions
- First Posted Date
- 2016-12-02
- Last Posted Date
- 2023-07-20
- Target Recruit Count
- 90
- Registration Number
- NCT02981069
- Locations
- 🇺🇸
University of Texas Health Science Center, San Antonio, Texas, United States
Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
- Conditions
- Interventions
- First Posted Date
- 2016-11-21
- Last Posted Date
- 2024-08-07
- Target Recruit Count
- 700
- Registration Number
- NCT02969798
- Locations
- 🇺🇸
The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
The Effects of Nicotinamide Adenine Dinucleotide (NAD) on Brain Function and Cognition
- Conditions
- Interventions
- First Posted Date
- 2016-10-24
- Last Posted Date
- 2021-09-02
- Target Recruit Count
- 46
- Registration Number
- NCT02942888
- Locations
- 🇺🇸
University of Texas Health San Antonio, San Antonio, Texas, United States
🇺🇸South Texas Veterans Healthcare System (STVHCS), San Antonio, Texas, United States